Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma

NCT03503630 is registered in ClinicalTrials.gov with Ali Shamseddine as lead sponsor.

NCT NCT03503630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03503630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma
Lead sponsor
Ali Shamseddine
Phase
Phase 2
Overall status
Unknown status
Start date
July 20, 2018
Completion date
July 2, 2024
Enrollment
44 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced rectal cancer